WallStreetZenWallStreetZen

NASDAQ: TRVI
Trevi Therapeutics Inc Stock Ownership - Who owns Trevi Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Trevi Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas SciasciaChief Scientific Officer2025-03-252,631$6.60
$17.36kSell
Thomas SciasciaChief Scientific Officer2025-03-252,631$1.43
$3.76kBuy
Jennifer L. GoodPresident CEO2025-03-215,263$1.43
$7.53kBuy
Jennifer L. GoodPresident CEO2025-03-215,263$6.58
$34.63kSell
Farrell SimonChief Commercial Officer2025-03-104,350$7.15
$31.10kSell
Farrell SimonChief Commercial Officer2025-03-1017,500$3.21
$56.18kBuy
Farrell SimonChief Commercial Officer2025-03-1063,813$3.91
$249.51kBuy
Farrell SimonChief Commercial Officer2025-03-1031,250$0.51
$15.97kBuy
Farrell SimonChief Commercial Officer2025-03-1076,963$6.73
$517.81kSell
Lisa DelfiniChief Financial Officer2025-01-085,000$0.51
$2.56kBuy

1 of 4

TRVI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRVI insiders and whales buy or sell their stock.

TRVI Shareholders

What type of owners hold Trevi Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mohamad Makhzoumi17.90%17,308,374$104.20MInsider
Carmen Chang17.90%17,308,374$104.20MInsider
Ali Behbahani17.90%17,308,374$104.20MInsider
Anthony A. Florence Jr.17.90%17,308,374$104.20MInsider
Paul Edward Walker17.90%17,308,374$104.20MInsider
Peter W. Sonsini17.90%17,308,374$104.20MInsider
Scott D. Sandell17.90%17,308,374$104.20MInsider
Forest Baskett16.92%16,359,426$98.48MInsider
Nea Management Company LLC11.76%11,370,376$68.45MInstitution
Frazier Life Sciences Management LP11.03%10,664,774$64.20MInstitution

1 of 3

TRVI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRVI30.28%69.72%Net BuyingNet Buying
PHAR0.01%0.00%
BCYC58.31%41.69%Net BuyingNet Selling
KROS70.41%29.59%Net BuyingNet Buying
ABUS27.17%72.83%Net SellingNet Selling
View Top Biotech Stocks

Trevi Therapeutics Stock Ownership FAQ

Who owns Trevi Therapeutics?

Trevi Therapeutics (NASDAQ: TRVI) is owned by 82.18% institutional shareholders, 189.27% Trevi Therapeutics insiders, and 0.00% retail investors. Mohamad Makhzoumi is the largest individual Trevi Therapeutics shareholder, owning 17.31M shares representing 17.90% of the company. Mohamad Makhzoumi's Trevi Therapeutics shares are currently valued at $105.06M.

If you're new to stock investing, here's how to buy Trevi Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.